Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Inolife Technologies Inc (OTC Pink - Limited Information:INOL)

0.0001
Delayed Data
As of Aug 31
 0.00 / 0.00%
Today’s Change
0.00
Today|||52-Week Range
0.00
-50.00%
Year-to-Date
SECTOR
Technology Services
INDUSTRY
Internet Software/Services
MARKET CAP
$90.4K

Company Description

InoLife Technologies, Inc. operates as a development stage service based healthcare product marketing company. The company currently market: a DNA testing for Plavix; pre disposition screening for certain genetic diseases, and ancestry and paternity tests. The principal users of products include healthcare providers including physicians, hospitals, and outpatient facilities, in addition to individuals with a direct need for the solutions. The company's products will be sold directly to consumers through e-commerce, direct sales, pharmacies, retailers, distributors and healthcare providers. InoLife Technologies was founded on November 12, 1998 and is headquartered in Raleigh, NC.

Contact Information

InoLife Technologies, Inc.
11 East 86th Street
New York New York 10028
P:(212) 348-5600
Investor Relations:

Employees

Shareholders

Individual stakeholders15.86%
Mutual fund holders--
Other institutional--

Top Executives

Elizabeth A. CironeChief Executive Officer